We are live on ! Find out more
PCMI

Princeton Capital Management Inc Portfolio holdings

AUM $198M
1-Year Est. Return 28.98%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+28.98%
3 Year Est. Return
+57.89%
5 Year Est. Return
10 Year Est. Return
AUM
$153M
AUM Growth
+$7.91M
Cap. Flow
+$1.62M
Cap. Flow %
1.06%
Top 10 Hldgs %
35.82%
Holding
78
New
2
Increased
27
Reduced
42
Closed
3

Top Sells

Rank Stock Value
1
FEIC
FEI COMPANY
FEIC
+$1.05M
2
WOLF icon
Wolfspeed
WOLF
+$378K
3
AAPL icon
Apple
AAPL
+$373K
4
GE icon
GE Aerospace
GE
+$275K
5
VZ icon
Verizon
VZ
+$233K

Sector Composition

Rank Sector Weight
1 Technology 35.03%
2 Industrials 20.67%
3 Communication Services 15.02%
4 Healthcare 12.13%
5 Real Estate 6.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QRVO icon
51
Qorvo
QRVO
$8.56B
$617K 0.4%
11,069
+2,794
+34% +$158K
PCRX icon
52
Pacira BioSciences
PCRX
$974M
$567K 0.37%
+16,565
New +$649K
DEA
53
Easterly Government Properties
DEA
$1.13B
$560K 0.37%
11,749
+3,810
+48% +$187K
DUK icon
54
Duke Energy
DUK
$94.5B
$524K 0.34%
6,547
-25
-0.4% -$2.07K
SGMO
55
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$496K 0.32%
107,145
-17,250
-14% -$87.7K
SUM
56
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$482K 0.32%
27,099
+10,750
+66% +$208K
ACIW icon
57
ACI Worldwide
ACIW
$5.34B
$454K 0.3%
23,445
-3,275
-12% -$62.2K
MXWL
58
DELISTED
Maxwell Technologies Inc
MXWL
$435K 0.28%
84,215
-10,720
-11% -$55.6K
MESO
59
Mesoblast
MESO
$2.16B
$418K 0.27%
48,498
-6,193
-11% -$57.8K
CRDF icon
60
Cardiff Oncology
CRDF
$80.1M
$380K 0.25%
1,176
+214
+22% +$78K
MRK icon
61
Merck
MRK
$323B
$374K 0.24%
6,281
-419
-6% -$24.5K
IRM icon
62
Iron Mountain
IRM
$36.2B
$296K 0.19%
7,897
-1,100
-12% -$42.4K
BIOL
63
DELISTED
Biolase, Inc.
BIOL
$289K 0.19%
13
-11
-46% -$196K
D icon
64
Dominion Energy
D
$59.1B
$286K 0.19%
3,845
MCK icon
65
McKesson
MCK
$103B
$200K 0.13%
1,200
ALOT icon
66
AstroNova
ALOT
$226M
$169K 0.11%
11,400
-2,000
-15% -$31.1K
SIOX
67
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$145K 0.09%
+1,298
New +$156K
MVIS icon
68
Microvision
MVIS
$86.9M
$114K 0.07%
5,518
-367
-6% -$8.68K
TURN
69
DELISTED
180 Degree Capital
TURN
$59K 0.04%
14,200
-1,867
-12% -$8.55K
CNSY
70
Cerenome, Inc. Common Stock
CNSY
$26.4M
0
TVIA
71
DELISTED
TerraVia Holdings, Inc. Common Stock
TVIA
$56K 0.04%
20,350
-5,525
-21% -$14.3K
DYAI icon
72
Dyadic International
DYAI
$36.3M
$27K 0.02%
17,700
-5,000
-22% -$7.63K
OTIC
73
DELISTED
Otonomy, Inc.
OTIC
-10,425
Closed -$166K
FEIC
74
DELISTED
FEI COMPANY
FEIC
-9,799
Closed -$1.05M
OSIR
75
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
-34,825
Closed -$177K

Similar funds

Princeton Capital Management Inc's Q3 2016 Portfolio in Review

As of Q3 2016, Princeton Capital Management Inc held 78 positions worth $153M, up 5.5% from $145M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Princeton Capital Management Inc's Q3 2016 filing shows 2 new, 27 increased, 42 reduced and 3 closed positions. Its largest new stake was Pacira BioSciences: 16,565 shares worth $567K. The largest sale was FEI COMPANY, an estimated $1.05M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 32% a quarter earlier, followed by Industrials and Communication Services.

  • Princeton Capital Management Inc's largest Q3 2016 buy was Pacira BioSciences: 16,565 shares worth $567K.
  • Princeton Capital Management Inc added most to NXP Semiconductors in Q3 2016, an estimated $1.86M increase.
  • Princeton Capital Management Inc's biggest Q3 2016 reduction was Wolfspeed, cutting an estimated $378K.
  • Princeton Capital Management Inc fully exited FEI COMPANY in Q3 2016, selling an estimated $1.05M.
  • Princeton Capital Management Inc's ten largest holdings make up 36% of its $153M portfolio in Q3 2016.
  • Princeton Capital Management Inc opened 2 new positions and closed 3 in Q3 2016.
  • Princeton Capital Management Inc's portfolio value rose 5.5% quarter-over-quarter to $153M.

Based on Princeton Capital Management Inc's 13F filing for Q3 2016, filed 3 Nov 2016.